Racial variations in lacosamide serum concentrations in adult patients with epilepsy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2020.116742
Abstract: Lacosamide (LCM) is a third-generation anti-epileptic drug (AED) for partial-onset epilepsy with minimal hepatic metabolism and drug-drug interactions. The impact of individual patient variables such as race on drug metabolism have been under-reported in AEDs… read more here.
Keywords: daily dose; lcm levels; drug; racial variations ... See more keywords